About Latvian Maritime Medicine Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Latvian Maritime Medicine Centre
During the past decade, Latvian Maritime Medicine Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
2012-04-01
2014-01-01
Terminated
150
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Latvian Maritime Medicine Centre"
#1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Latvian Maritime Medicine Centre
According to Clinical.Site data, the most researched conditions in "Latvian Maritime Medicine Centre" are
"Ulcerative Colitis" (3 trials), "Multiple Sclerosis" (2 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Latvian Maritime Medicine Centre" in a lesser frequency.
Clinical Trials Intervention Types at Latvian Maritime Medicine Centre
Most popular intervention types in "Latvian Maritime Medicine Centre" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Mesalamine" (2 trials), "Interferon beta-1a" (1 trials), "Ozanimod" (1 trials) and "Placebo to interferon beta-1a" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Latvian Maritime Medicine Centre
The vast majority of trials in "Latvian Maritime Medicine Centre" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Latvian Maritime Medicine Centre
Currently, there are NaN active trials in "Latvian Maritime Medicine Centre".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Latvian Maritime Medicine Centre,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Latvian Maritime Medicine Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".